N-((2R)-2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide
| CAS No. | 391210-10-9 |
|---|---|
| MDL No. | MFCD08435926 |
| MF | C16H14F3IN2O4 |
| MW | 482.19 |
| InChI Key | SUDAHWBOROXANE-SECBINFHSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
PD 0325901 is a hydroxamic acid ester derived from benzhydroxamic acid (N-hydroxybenzamide), with the hydroxamic acid group converted to a 2,3-dihydroxypropyl ester. The benzene ring is substituted at position 2 with a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 with fluorines (R enantiomer). It functions as an EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor and an antineoplastic agent. It is also a secondary amino compound, a monofluorobenzene, an organoiodine compound, a propane-1,2-diol, and a difluorobenzene.
| CAS No. | 391210-10-9 |
|---|---|
| Product Name | N-((2R)-2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide |
Biological Targets
MAP2K1·MAP2K2
Associated Conditions
cancer·low grade glioma·colorectal cancer·neurofibromatosis type 1·neoplasm·
* The information provided here is compiled from public sources and is for reference only.
